Cargando…

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves

Introduction: There were few data about the clinical profiles and long-term outcomes in Chinese patients with atrial fibrillation (AF) and bioprosthetic valves. Methods: The retrospective study enrolled 903 patients with bioprosthetic valve replacement at our hospital and discharged with a diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Jiameng, Yang, Yanmin, Zhu, Jun, Wu, Shuang, Wang, Juan, Zhang, Han, Shao, Xinghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222517/ https://www.ncbi.nlm.nih.gov/pubmed/34179131 http://dx.doi.org/10.3389/fcvm.2021.665124

Ejemplares similares

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
por: Cao, Yalin, et al.
Publicado: (2022)

Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves
por: Williams, David F., et al.
Publicado: (2021)

Left Atrial Thrombus in a Patient with Mitral Bioprosthetic Valve
por: Tas, Muhammed Hakan, et al.
Publicado: (2013)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021)

Residual Bioprosthetic Valve Immunogenicity: Forgotten, Not Lost
por: Human, Paul, et al.
Publicado: (2022)

Bioprosthetic valve monitoring in patients with carcinoid heart disease
por: Honan, Kevin A., et al.
Publicado: (2023)

Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
por: Ruge, Hendrik, et al.
Publicado: (2021)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Transcatheter Mitral Valve-in-Valve Implantation With a New Transcatheter Heart Valve for Bioprosthetic Degeneration
por: Lu, Yuntao, et al.
Publicado: (2022)

Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis
por: Petrou, Emmanouil, et al.
Publicado: (2014)

Bioprosthetic Heart Valves: Upgrading a 50-Year Old Technology
por: Li, Kan Yan Chloe
Publicado: (2019)

Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses
por: Lange, Rüdiger, et al.
Publicado: (2022)

Long-term clinical outcome of atrial fibrillation ablation in patients with history of mitral valve surgery
por: Almorad, Alexandre, et al.
Publicado: (2022)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation
por: Chu, Gordon, et al.
Publicado: (2020)

Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study
por: Suo, Ni, et al.
Publicado: (2022)

Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2021)

Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019)

Reversal of Bioprosthetic Aortic Valve Thrombosis Using Rivaroxaban—A Case Report
por: Sharma, Harish, et al.
Publicado: (2020)

Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far
por: Sawaya, Fadi, et al.
Publicado: (2019)

Bioprosthetic Valve Fracturing: In vitro Testing of Edwards PERIMOUNT Model P 2900
por: Ruge, Hendrik, et al.
Publicado: (2022)

Performance of xenogeneic pulmonary visceral pleura as bioprosthetic heart valve cusps in swine
por: Lu, Xiao, et al.
Publicado: (2023)

Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
por: Li, Guan-Yi, et al.
Publicado: (2021)

Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed Bioprosthetic Mitral Valve
por: Kang, Do-Yoon, et al.
Publicado: (2018)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Case report: Transapical transcatheter double valve-in-valve replacement of degenerated aortic and mitral bioprosthetic valves with limited radiopaque landmarks
por: Zhou, Jiawei, et al.
Publicado: (2022)

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study
por: Girerd, Nicolas, et al.
Publicado: (2011)

Intravenous thrombolysis for bioprosthetic valve thrombosis
por: Adrichem, Rik, et al.
Publicado: (2023)

Safety and efficacy of direct oral anticoagulants in bioprosthetic valves: A systematic review and meta-analysis
por: Bakr, Lubna, et al.
Publicado: (2023)

Fibrin deposition on bovine pericardium tissue used for bioprosthetic heart valve drives its calcification
por: Poitier, Bastien, et al.
Publicado: (2023)

Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
por: Cameron, Chris, et al.
Publicado: (2014)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
por: Lee, Oh-Hyun, et al.
Publicado: (2021)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

First Asian Experience with the BASILICA Technique in Failed Bioprosthetic Aortic Valve
por: Kook, Hyungdon, et al.
Publicado: (2021)

ABO blood type and risk of porcine bioprosthetic aortic valve degeneration: SWEDEHEART observational cohort study
por: Persson, Michael, et al.
Publicado: (2019)

Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study
por: De Luca, Leonardo, et al.
Publicado: (2020)

Bioprosthetic valve thrombosis after transcatheter aortic valve replacement and pulmonary embolism due to heparin-induced thrombocytopenia: a case report
por: Faucher, Loïc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jk3p702131ij4rkoim5phlsgpt